| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Nicotinamide Riboside | Cataract | 1 | PM | 33297791 | 📋 | Protective Effects of Nicotinamide Riboside on H 2 O 2-induced Oxidative Damage in Lens Epithelial Cells |
| Nicotinamide Riboside | Diabetic Retinopathy | 1 | PM | 33053398 | 📋 | Hyperglycemia-reduced NAD + biosynthesis impairs corneal epithelial wound healing in diabetic mice |
| Nicotinamide Riboside | Glaucoma | 4 | PM | 37880000 | 📋 | Glaucoma: neuroprotection with NAD-based therapeutic interventions |
| Nicotinamide Riboside | Glaucoma | 3 | PM | 37754233 | 📋 | Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model |
| Nicotinamide Riboside | Glaucoma | 2 | PM | 36916064 | 📋 | The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma |
| Nicotinamide Riboside | Glaucoma | 1 | PM | 34208613 | 📋 | Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage |
| Nicotinamide Riboside | Light-Induced Retinal Damage | 1 | PM | 32852543 | 📋 | Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration |
| Nicotinamide Riboside | Ocular Disorders | 1 | PM | 32820458 | 📋 | Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration |
